Rkg Lifescience Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 0.50 M
as on 15-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 Cr
as on 15-12-2024
- Revenue %
(FY 2022)
- Profit -38.17%
(FY 2022)
- Ebitda -38.17%
(FY 2022)
- Net Worth -1.38%
(FY 2022)
- Total Assets -0.03%
(FY 2022)
About Rkg Lifescience
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹5.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jayram Mekhale and Dnyanoba Wakle serve as directors at the Company.
- CIN/LLPIN
U24100MH2013PTC240830
- Company No.
240830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rkg Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayram Mekhale  | Director | 04-Dec-2014 | Current |
| Dnyanoba Wakle | Director | 04-Dec-2014 | Current |
Financial Performance of Rkg Lifescience.
Rkg Lifescience Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 38.17% decrease in profit. The company's net worth dipped by a decrease of 1.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rkg Lifescience?
In 2018, Rkg Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sunlight Dealcom Private LimitedActive 15 years 10 months
Jayram Mekhale and Dnyanoba Wakle are mutual person
- Pinnacle Bluebird India Ads Private LimitedActive 9 years 3 months
Dnyanoba Wakle is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
New India Co-Operative Bank Ltd. Creation Date: 12 Aug 2013 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Rkg Lifescience?
Unlock and access historical data on people associated with Rkg Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rkg Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rkg Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
